Grantham, Mayo, Van Otterloo & Co (GMO)
ALGN icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Align Technology ALGN Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio ALGN Stock Details ALGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-21,125
Closed -$2.65M – 657
2025
Q3 		$2.65M Buy
21,125
+15,133
+253% +$2.37M 0.01% 351
2025
Q2 		$1.13M Buy
5,992
+1,831
+44% +$323K ﹤0.01% 461
2025
Q1 		$661K Buy
+4,161
New +$817K ﹤0.01% 513

Other funds holding ALGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s ALGN Position: Q4 2025 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Align Technology (ALGN) in Q4 2025, closing a stake of 21,125 shares — an estimated $2.65M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ALGN in Q1 2025 and held it in 3 quarters. The position peaked at $2.65M in Q3 2025. 666 funds tracked by Wall St. Rank hold ALGN as of Q4 2025.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Align Technology position as of Q4 2025 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 21,125 Align Technology shares in Q4 2025, an estimated $2.65M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Align Technology in Q1 2025 and held it in 3 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Align Technology position peaked at $2.65M in Q3 2025.
  • 666 funds tracked by Wall St. Rank held Align Technology as of Q4 2025.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2025, filed 17 Feb 2026.